Daily Archives: November 24, 2021
WHO issues guidelines on the treatment of children with multisystem inflammatory syndrome associated with COVID-19.
24 Nov, 2021 | 08:51h | UTCGuideline: Living guidance for clinical management of COVID-19 – World Health Organziation
Related:
An Update on Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2.
Ten Things to Know About Multisystem Inflammatory Syndrome in Children (MIS-C).
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: An Overview and Comparison.
Cohort study: Six month follow-up of Multisystem Inflammatory Syndrome in Children.
Clinical Update: Acute covid-19 and multisystem inflammatory syndrome in children
Cutaneous findings in SARS-CoV-2-associated Multisystem Inflammatory Disease in Children (MIS-C)
SR: Multisystem inflammatory syndrome in children related to COVID-19
Opinion from thirty two ministers of health: The world must act now to be prepared for future health emergencies.
24 Nov, 2021 | 08:49h | UTCThe world must act now to be prepared for future health emergencies – The BMJ
Related:
Perspective | Learning from crisis: building resilient systems to combat future pandemics.
Opinion | The future of pandemic preparedness: agile coordination around clinical trials.
Commentary on Twitter
Solidarity is key to protect the world from pandemics. This call by over 30 governments for a #PandemicTreaty to prepare for & respond to pandemics shows collaboration at work. The upcoming #WHASpecial session is a historic opportunity to make the world safer. https://t.co/98TgPce03t
— Tedros Adhanom Ghebreyesus (@DrTedros) November 23, 2021
Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA.
24 Nov, 2021 | 08:47h | UTCRelated: WHO Guidance for improving acceptance and uptake of COVID-19 vaccines
Cohort study found the risk of myocardial infarction may be best predicted by the number of apolipoprotein B containing lipoproteins.
24 Nov, 2021 | 08:41h | UTCAssociation of Apolipoprotein B–Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Particle Concentration, Type, and Content – JAMA Cardiology (link to abstract – $ for full-text)
Commentaries:
ApoB Gains Ground as Best Lipid Predictor of MI Risk – TCTMD
Study finds risk of MI best captured by number of apolipoprotein B lipoproteins – MedicalResearch
Commentary on Twitter
Study from @marstonMD @TIMIStudyGroup et al found lipid-associated risk for myocardial infarction is best captured by the number of apoB-containing lipoproteins, independent from lipid content (cholesterol or TG) or type of lipoprotein (LDL or TG-rich) https://t.co/UBby6mtj6e
— JAMA Cardiology (@JAMACardio) November 13, 2021
Review: COVID-19-associated Invasive Fungal Infection.
24 Nov, 2021 | 08:48h | UTCCOVID-19-associated Invasive Fungal Infection – Open Forum Infectious Diseases
Related:
Consensus Guideline: Defining and managing COVID-19-associated pulmonary aspergillosis
Bacterial and fungal superinfections in critically ill patients with COVID-19
Invasive Fungal Disease complicating COVID-19: when it rains it pours
A national strategy to diagnose COVID-19 associated invasive fungal disease in the ICU
Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients
Commentary on Twitter
A new article in OFID reviews COVID-19-associated fungal infections and addresses gaps in knowledge relating to the epidemiology, diagnosis and management of these infections: https://t.co/JIkkW70zHI#IDSAJournals #OpenForumInfectDis @PaulSaxMD @DrJLi @jobadd @DrPappasID pic.twitter.com/bPmFdKkjmb
— IDSA (@IDSAInfo) November 21, 2021
AGA Clinical practice update on management of chronic gastrointestinal pain in disorders of gut–brain interaction.
24 Nov, 2021 | 08:42h | UTC
Viewpoint: The growing phenomenon of “virtual-first” primary care.
24 Nov, 2021 | 08:39h | UTCThe Growing Phenomenon of “Virtual-First” Primary Care – JAMA (free for a limited period)
We expected people with asthma to fare worse during COVID. Turns out they’ve had a break.
24 Nov, 2021 | 08:44h | UTC
Safety analysis of RCTs showed Alzheimer’s drug Aducanumab caused brain swelling in 35% of patients, and 26.0% experienced associated symptoms (e.g., headache, confusion, dizziness, and nausea).
24 Nov, 2021 | 08:35h | UTCCommentary: Biogen Alzheimer’s drug shows brain swelling in 35% of patients – MedicalXpress
Commentary on Twitter
Amyloid-related imaging abnormalities occurred in ~ 40% of participants in the phase 3 studies of aducanumab. Approximately one-quarter of patients with amyloid-related imaging abnormalities experience symptoms https://t.co/TnUPXT686l
— JAMA Neurology (@JAMANeuro) November 22, 2021
Three Neurologic Societies, Including the AAN, Issue Strong Position Statement on Aducanumab.
24 Nov, 2021 | 08:36h | UTCRelated:
Editorial: Aducanumab for Alzheimer’s disease?
FDA approvement of Alzheimer’s drug sparks controversy among doctors.
Commentary on Twitter
Decisions With Patients and Families Regarding #Aducanumab in Alzheimer Disease, With Recommendations for Consent—Read the full AAN @AANMember Position Statement: https://t.co/ckoIVRi4DE #Neurology pic.twitter.com/q8TSU67zm9
— Neurology Journal (@GreenJournal) November 19, 2021
Systematic Review: Renal denervation may have a modest effect in improving 24h ambulatory blood pressure monitoring (reduction in SBP by 5.29 mmHg and DBP by 3.75 mmHg) but does not improve major cardiovascular outcomes and renal function.
24 Nov, 2021 | 08:33h | UTCOriginal Review: Renal denervation for resistant hypertension – Cochrane Library
Commentary on Twitter
Does renal #denervation improve outcomes in people with resistant #hypertension?❤️
Our newly updated @CochraneLibrary #SystematicReview looks at the evidence of 15 RCTs involving 1416 participants: https://t.co/NkVMHW46s6#CochraneEvidence #blogshot pic.twitter.com/TBqli3e9ai
— Cochrane Hypertension (@CochraneHTN) November 23, 2021
Chest Pain: Who needs additional testing beyond ECG and Troponin?
24 Nov, 2021 | 08:28h | UTCChest Pain: Who Needs Additional Testing Beyond ECG and Troponin? – JACC: Case Reports
RCT: A brief 5:2 diet advice resulted in similar weight loss at one year vs. a standard multicomponent weight-management advice (-2.6kg vs. -1.9kg, p = 0.37).
24 Nov, 2021 | 08:29h | UTCA randomised controlled trial of the 5:2 diet – PLOS One
Commentary: Fasting 2 days a week can help obese people keep off the weight with modest results, study finds – CNN
A prospective cohort study showed a 3.1% risk for recurrent venous thromboembolism at 90 days in patients with subsegmental pulmonary embolism managed without anticoagulation.
24 Nov, 2021 | 08:31h | UTCRisk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation: A Multicenter Prospective Cohort Study – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentary on Twitter
First prospective study including patients with isolated SSPE managed without anticoagulation published in @AnnalsofIM. Rate of recurrent VTE is 3.1% . Nice collaboration between @INNOVTE1 and @canvector funded by @HeartandStroke https://t.co/GdcbM1fRp1 @OttMethodsCentr
— Marc Carrier (@MarcCarrier1) November 23, 2021
Review: A Road Map of the Axial Spondyloarthritis Continuum.
24 Nov, 2021 | 08:27h | UTCA Road Map of the Axial Spondyloarthritis Continuum – Mayo Clinic Proceedings
Opinion: Texting thumb, trigger finger, gamer’s thumb and other smartphone injuries.
24 Nov, 2021 | 08:24h | UTCTexting Thumb, Trigger Finger, Gamer’s Thumb and Other Smartphone Injuries – Scientific American
Review: Prevention and treatment of atrial fibrillation via risk factor modification.
24 Nov, 2021 | 08:25h | UTC
Systematic Review: Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
24 Nov, 2021 | 08:22h | UTCSummary: Selective serotonin reuptake inhibitors for stroke recovery – Cochrane Library
Original Article: Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery – Cochrane Library
Related:
RCT: Routine treatment with fluoxetine does not reduce the incidence of depression after stroke.
[Abstract Only] Randomized trial: Fluoxetine does not improve functional recovery after acute stroke
Randomized Trial: Effects of Fluoxetine on Functional Outcomes After Acute Stroke
Commentary on Twitter
Selective #serotonin reuptake inhibitors for #stroke recovery https://t.co/7R5bijz49e Updated @CochraneStroke systematic review: 'reduced risk of future depression by about a quarter, but led to a slight increase in the risk of seizures & increased the risk of bone fractures.'
— The Cochrane Library (@CochraneLibrary) November 19, 2021
Systematic Review: Vaccines for preventing rotavirus diarrhea.
24 Nov, 2021 | 08:20h | UTCVaccines for preventing rotavirus diarrhoea: vaccines in use – Cochrane Library
Commentary: Vaccines for preventing rotavirus diarrhoea: an updated Cochrane review – Cochrane Library
Optimal dose of aripiprazole for augmentation therapy of antidepressant-refractory depression: preliminary findings based on a systematic review and dose–effect meta-analysis.
24 Nov, 2021 | 08:23h | UTC
Commentary on Twitter
Low-doses of aripiprazole [2-5 mg] as augmentation treatment for depression might achieve the optimal balance between efficacy, tolerability and acceptability, per this meta-analysis (certainty of evidence low to moderate)https://t.co/aTkcQOsORp
— Awais Aftab (@awaisaftab) November 21, 2021